Marc van der Waude, Marc van der Waude, Nov 01, 2009
The purpose of this contribution is to explore the status types that settlements and reverse payments could have under Article 81 EC. It seeks to identify the elements of the legal tests which could possibly be applied to assess the legality of such settlements and, in particular, those providing for a value transfer from the originator to the generic firm. This will be done as follows: Section 2 summarizes the main findings of the Final Report on settlement agreements; Section 3 makes an inventory of relatively old case law that dealt with comparable issues or those related to patent settlement agreements; and Section 4 makes an attempt to distill a legal test from the two previous sections for the assessment of patent settlement agreements between originator and generic firms under EC competition law.
Featured News
Newsmax Legal Analysts Push Back on Trump DOJ’s Antitrust Probe of TV Networks
Oct 12, 2026 by
CPI
EU Launches In-Depth Antitrust Probe Into XXXLutz’s Takeover of German Furniture Rival Porta
Oct 12, 2026 by
CPI
Starbucks Says It Has No Plans to Buy Chipotle Mexican Grill
Oct 12, 2026 by
CPI
Warren Urges Antitrust Scrutiny of Kroger’s $1.65 Billion Giant Eagle Deal
Oct 12, 2026 by
CPI
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight
Oct 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton